MOMENTA PHARMACEUTICALS INC·4

Feb 11, 2:13 PM ET

MOMENTA PHARMACEUTICALS INC 4

4 · MOMENTA PHARMACEUTICALS INC · Filed Feb 11, 2016

Insider Transaction Report

Form 4
Period: 2016-02-09
Roach James M.
Senior VP, Development and Chi
Transactions
  • Sale

    Common Stock

    2016-02-09+17,100107,541 total
  • Award

    Stock Option (Right to Buy)

    2016-02-09+34,20034,200 total
    Exercise: $10.83From: 2017-02-09Exp: 2026-02-09Common Stock (34,200 underlying)
Footnotes (2)
  • [F1]Represents 17,100 shares of restricted common stock, $0.0001 par value per share, awarded pursuant to the Company's 2013 Stock Incentive Plan, and subject to a restricted stock agreement to be entered between the Company and Mr. Roach. Pursuant to the restricted stock agreement, 25% of the shares of restricted Common Stock shall vest on February 9, 2017 and an additional 6.25% of the shares of restricted Common Stock shall vest at the end of each three-month period thereafter.
  • [F2]Represents options granted by the issuer pursuant to the issuer's 2013 Stock Incentive Plan. Subject to certain criteria such options vest with 25% shares of such option one year following the date of grant and 6.25% shares of such option shall vest at the end of each three-month period thereafter.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -